TPST Overview

Butterfly Network Update: Butterfly Network's shares rose 6.04% after announcing CEO Joseph DeVivo and Interim CFO Megan Carlson will participate in investor meetings at the Evercore Healthcare Conference on December 2, 2025, highlighting their handheld ultrasound technology.

Citius Pharmaceuticals Collaboration: Citius Pharmaceuticals saw a 7.90% increase in shares after announcing a collaboration with Verix to utilize its AI-powered Tovana platform for the U.S. commercialization of LYMPHIR, an FDA-approved immunotherapy for cutaneous T-cell lymphoma.

General Market Activity: ProQR Therapeutics, Perrigo Company, and Tempest Therapeutics also experienced share price increases, with Tempest announcing plans to acquire CAR-T programs to enhance its pipeline.

Other Stocks Performance: Iterum Therapeutics and Processa Pharmaceuticals had minor share price movements without any new updates, reflecting varied investor sentiment in the biotech sector.

U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones down 0.23%, while the NASDAQ and S&P 500 saw slight gains of 0.19% and 0.08%, respectively.

Lowe's Earnings Report: Lowe's Companies, Inc. shares rose over 5% after exceeding profit expectations for Q3, reporting adjusted earnings per share of $3.06, although sales fell slightly short.

Notable Stock Movements: WeShop Holdings saw a dramatic 413% increase following its Nasdaq debut, while Agios Pharmaceuticals and Carver Bancorp experienced significant declines of 50% and 51%, respectively.

Commodity and Economic Updates: Oil prices fell by 2.4% to $59.26, while gold and silver saw slight increases. The U.S. trade deficit narrowed to $59.6 billion in August, with a notable decline in crude oil inventories.

U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite gaining over 100 points, while the Dow fell by 0.20%. The S&P 500 also saw a slight increase of 0.35%.

Target Corporation Earnings Report: Target reported a third-quarter profit that exceeded expectations but fell short on sales, leading to a reduction in its full-year earnings outlook.

Notable Stock Movements: WeShop Holdings saw a significant increase of 148% following its Nasdaq debut, while Freight Technologies surged 77% after launching a new AI platform. Conversely, Inspire Veterinary Partners and Carver Bancorp experienced substantial declines.

Commodity and Economic Updates: Oil prices dropped by 2.3%, while gold and silver saw slight increases. Additionally, U.S. crude oil inventories fell more than expected, and the trade deficit narrowed significantly in August.

Acquisition Announcement: Tempest Therapeutics Inc. is experiencing a significant drop in share price following its announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience, which will result in substantial shareholder dilution.

Leadership Change: The acquisition will lead to a leadership change, with Factor co-founder Dr. Matt Angel set to replace Stephen Brady as CEO upon the deal's expected closing in early 2026.

Pipeline Expansion: The deal expands Tempest's pipeline by adding the clinical-stage TPST-2003 program and is projected to extend the company's cash runway into mid-2027.

Market Reaction: Following the announcement, TPST shares fell by 50% to $4.60, nearing its 52-week low, with bearish signals noted across various price trends according to Benzinga Edge data.